MedPath

Bowel Preparation for Colonoscopy With Oral Lactulose

Completed
Conditions
Colonoscopy Preparation
Colonoscopy
Registration Number
NCT06282367
Lead Sponsor
Josue Aliaga
Brief Summary

Background and Aims: The quality of colonoscopy is critically influenced by bowel preparation. Polyethylene glycol (PEG) is considered the gold standard regimen for bowel preparation, however due to the necessity of large volume of patient's tolerance is impaired, especially in the elderly population. Lactulose has been adopted in a few centers as a novel alternative for colonoscopy preparation. This study aimed to investigate the efficacy-safety profile of a lactulose-based bowel preparation in comparison to PEG for colonoscopy.

Methods: Prospective non-blinded comparative study, developed in two tertiary centers from July 2021 to April 2023. Outpatients undergoing colonoscopy were randomly divided into 2 groups: Group 1 (111 patients): PEG and Group 2 (111 patients): Lactulose. The following clinical outcomes were assessed for each group: degree of bowel clearance using the Boston Score, colorectal polyp detection rate, adenoma detection rate, tolerability and side effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
222
Inclusion Criteria
  • Patients age ≥ 18 years
  • Colorectal cancer screening
  • Lower gastrointestinal bleeding
  • Iron deficiency anemia
  • Chronic diarrhea
Exclusion Criteria
  • Patients with previous colorectal surgery
  • Pregnant
  • Emergency colonoscopies
  • Use of any other scheme or substance for bowel preparation different from those studied
  • Incomplete information
  • Clinical conditions considered unsuitable for sedation or colonoscopy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Degree of bowel cleansing using the Boston score21 month

minimum value: 0 (worse outcome: inadequate bowel preparation); maximum value: 9 (better outcome: adequate bowel preparation)

Secondary Outcome Measures
NameTimeMethod
adenomas detection rate21 months

Trial Locations

Locations (1)

Jose Agurto Tello Hospital

🇵🇪

Lima, Peru

© Copyright 2025. All Rights Reserved by MedPath